Literature DB >> 10583109

Guidelines for management of Bowen's disease. British Association of Dermatologists.

N H Cox1, D J Eedy, C A Morton.   

Abstract

These guidelines for management of Bowen's disease have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583109     DOI: 10.1046/j.1365-2133.1999.03100.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  12 in total

1.  A Case of Pigmented Bowen's Disease.

Authors:  Jung Woo Lee; Jae Hur; Kwang Yeoll Yeo; Hee Joon Yu; Joung Soo Kim
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

Review 2.  [Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma].

Authors:  R-M Szeimies; S Karrer; H Bäcker
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

3.  Bowen disease.

Authors:  Nadia Akhdari; Said Amal; Salwa Ettalbi
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

4.  Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen disease.

Authors:  Sue Kyung Kim; Ji-Youn Park; Hyo Sang Song; You-Sun Kim; You Chan Kim
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

5.  Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.

Authors:  Selin Tokez; Marlies Wakkee; Marieke Louwman; Eline Noels; Tamar Nijsten; Loes Hollestein
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

6.  [Side effects of topical photodynamic therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2007-07       Impact factor: 0.751

Review 7.  Interventions for cutaneous Bowen's disease.

Authors:  Fiona J Bath-Hextall; Rubeta N Matin; David Wilkinson; Jo Leonardi-Bee
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

8.  Bowen's disease - a review of newer treatment options.

Authors:  Thorsten Neubert; Percy Lehmann
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

9.  Environmental scan of anal cancer screening practices: worldwide survey results.

Authors:  Jigisha Patel; Irving E Salit; Michael J Berry; Alexandra de Pokomandy; Mayura Nathan; Fred Fishman; Joel Palefsky; Jill Tinmouth
Journal:  Cancer Med       Date:  2014-04-16       Impact factor: 4.452

10.  Acantholytic Variant of Bowen's Disease with Micro-invasive Squamous Cell Carcinoma: A Case Report of a Unique Variant.

Authors:  Kanthilatha Pai; Shricharith Shetty; J Padmapriya; Sathish Pai; Lakshmi Rao
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.